Benjamin F. Edwards & Company’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $32K | Sell |
391
-3
| -0.8% | -$246 | ﹤0.01% | 1435 |
|
2024
Q1 | $35K | Sell |
394
-39
| -9% | -$3.46K | ﹤0.01% | 1395 |
|
2023
Q4 | $42K | Buy |
433
+249
| +135% | +$24.2K | ﹤0.01% | 1293 |
|
2023
Q3 | $16K | Sell |
184
-44
| -19% | -$3.83K | ﹤0.01% | 1292 |
|
2023
Q2 | $20K | Hold |
228
| – | – | ﹤0.01% | 1275 |
|
2023
Q1 | $22K | Sell |
228
-18
| -7% | -$1.74K | ﹤0.01% | 1251 |
|
2022
Q4 | $25K | Buy |
246
+43
| +21% | +$4.37K | ﹤0.01% | 1230 |
|
2022
Q3 | $17K | Sell |
203
-1,026
| -83% | -$85.9K | ﹤0.01% | 1292 |
|
2022
Q2 | $102K | Sell |
1,229
-1,526
| -55% | -$127K | ﹤0.01% | 850 |
|
2022
Q1 | $212K | Sell |
2,755
-758
| -22% | -$58.3K | 0.01% | 671 |
|
2021
Q4 | $310K | Buy |
3,513
+286
| +9% | +$25.2K | 0.01% | 571 |
|
2021
Q3 | $249K | Sell |
3,227
-680
| -17% | -$52.5K | 0.01% | 603 |
|
2021
Q2 | $326K | Sell |
3,907
-168
| -4% | -$14K | 0.02% | 529 |
|
2021
Q1 | $308K | Buy |
4,075
+1,012
| +33% | +$76.5K | 0.02% | 570 |
|
2020
Q4 | $269K | Buy |
3,063
+1,542
| +101% | +$135K | 0.02% | 560 |
|
2020
Q3 | $116K | Buy |
1,521
+314
| +26% | +$23.9K | 0.01% | 708 |
|
2020
Q2 | $149K | Buy |
1,207
+1,188
| +6,253% | +$147K | 0.01% | 638 |
|
2020
Q1 | $2K | Hold |
19
| – | – | ﹤0.01% | 1578 |
|
2019
Q4 | $2K | Sell |
19
-920
| -98% | -$96.8K | ﹤0.01% | 1756 |
|
2019
Q3 | $63K | Buy |
939
+893
| +1,941% | +$59.9K | ﹤0.01% | 857 |
|
2019
Q2 | $4K | Buy |
46
+19
| +70% | +$1.65K | ﹤0.01% | 1660 |
|
2019
Q1 | $2K | Hold |
27
| – | – | ﹤0.01% | 1600 |
|
2018
Q4 | $2K | Hold |
27
| – | – | ﹤0.01% | 1578 |
|
2018
Q3 | $3K | Hold |
27
| – | – | ﹤0.01% | 1460 |
|
2018
Q2 | $3K | Hold |
27
| – | – | ﹤0.01% | 1460 |
|
2018
Q1 | $2K | Hold |
27
| – | – | ﹤0.01% | 1502 |
|
2017
Q4 | $2K | Sell |
27
-15
| -36% | -$1.11K | ﹤0.01% | 1441 |
|
2017
Q3 | $4K | Hold |
42
| – | – | ﹤0.01% | 1307 |
|
2017
Q2 | $4K | Buy |
+42
| New | +$4K | ﹤0.01% | 1249 |
|